CAD-31

N/A

Report date: 2025/01/26 16:55:51
NME

Base Information

Drug NameCAD-31
Drug Alias Namehuman embryonic stem cell-derived neural precursor replication stimulator (Salk Institute)CAD-31
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionNeuroprotectantsStem cells stimulants
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSalk Institute for Biological Studies
China Registration ClassN/A

Develop Information

Active CompaniesSalk Institute for Biological Studies
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A